loadpatents
name:-0.011635065078735
name:-0.011697053909302
name:-0.0034220218658447
Kamenecka; Theodore M. Patent Filings

Kamenecka; Theodore M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kamenecka; Theodore M..The latest application filed is for "halo-substituted piperidines as orexin receptor modulators".

Company Profile
3.9.10
  • Kamenecka; Theodore M. - Palm Beach Gardens FL
  • Kamenecka; Theodore M. - Palms Beach Gardens FL
  • Kamenecka; Theodore M - Palm Beach Gardens FL
  • Kamenecka; Theodore M. - North Palm Beach FL
  • Kamenecka; Theodore M. - San Diego CA
  • Kamenecka; Theodore M. - North Brunswick NJ
  • Kamenecka; Theodore M. - Atlantic Highlands NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Halo-substituted piperidines as orexin receptor modulators
Grant 11,434,236 - Kamenecka , et al. September 6, 2
2022-09-06
Halo-substituted Piperidines As Orexin Receptor Modulators
App 20210214348 - Kamenecka; Theodore M. ;   et al.
2021-07-15
Halo-substituted piperidines as orexin receptor modulators
Grant 10,894,789 - Kamenecka , et al. January 19, 2
2021-01-19
Halo-substituted Piperidines As Orexin Receptor Modulators
App 20190135800 - Kamenecka; Theodore M. ;   et al.
2019-05-09
Difluoropyrrolidines as orexin receptor modulators
Grant 10,221,170 - Kamenecka , et al.
2019-03-05
Substituted prolines/piperidines as orexin receptor antagonists
Grant 9,896,452 - Kamenecka , et al. February 20, 2
2018-02-20
Difluoropyrrolidines As Orexin Receptor Modulators
App 20170226103 - Kamenecka; Theodore M. ;   et al.
2017-08-10
Substituted Prolines / Piperidines As Orexin Receptor Antagonists
App 20170101410 - Kamenecka; Theodore M. ;   et al.
2017-04-13
Substituted prolines / piperidines as orexin receptor antagonists
Grant 9,499,517 - Kamenecka , et al. November 22, 2
2016-11-22
Substituted prolines/piperidines as orexin receptor antagonists
Grant 9,440,982 - Kamenecka , et al. September 13, 2
2016-09-13
Substituted Prolines / Piperidines As Orexin Receptor Antagonists
App 20140364432 - KAMENECKA; Theodore M. ;   et al.
2014-12-11
Substituted Prolines / Piperidines As Orexin Receptor Antagonists
App 20140364433 - KAMENECKA; Theodore M. ;   et al.
2014-12-11
Substituted Pyrimidinyl-amines As Protein Kinase Inhibitors
App 20100298312 - Kamenecka; Theodore M. ;   et al.
2010-11-25
Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
Grant 7,700,591 - Goble , et al. April 20, 2
2010-04-20
Bipyridyl amides as modulators of metabotropic glutamate receptor-5
App 20070149547 - Bonnefous; Celine ;   et al.
2007-06-28
Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
App 20070027321 - Kamenecka; Theodore M. ;   et al.
2007-02-01
Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
App 20060069088 - Goble; Stephen D. ;   et al.
2006-03-30
Substituted nipecotyl derivatives as inhibitors of cell adhesion
Grant 6,403,584 - de Laszlo , et al. June 11, 2
2002-06-11
Substituted ureas as cell adhesion inhibitors
Grant 6,353,099 - DeLaszlo , et al. March 5, 2
2002-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed